A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting

NCT06488170 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Tildrakizumab

Sponsor

Almirall, S.A.